Kania G - Search Results

1

Experimental Mouse Model of Bleomycin-Induced Skin Fibrosis.

Błyszczuk P, Kozlova A, Guo Z, Kania G, Distler O. Błyszczuk P, et al. Among authors: kania g. Curr Protoc Immunol. 2019 Sep;126(1):e88. doi: 10.1002/cpim.88. Curr Protoc Immunol. 2019. PMID: 31483105

2

Differentiation of mouse embryonic stem cells into pancreatic and hepatic cells.

Kania G, Blyszczuk P, Czyz J, Navarrete-Santos A, Wobus AM. Kania G, et al. Methods Enzymol. 2003;365:287-303. doi: 10.1016/s0076-6879(03)65021-4. Methods Enzymol. 2003. PMID: 14696354

3

The generation of insulin-producing cells from embryonic stem cells--a discussion of controversial findings.

Kania G, Blyszczuk P, Wobus AM. Kania G, et al. Int J Dev Biol. 2004 Dec;48(10):1061-4. doi: 10.1387/ijdb.041925gk. Int J Dev Biol. 2004. PMID: 15602691 Free article.

4

Pluripotency: capacity for in vitro differentiation of undifferentiated embryonic stem cells.

Wiese C, Kania G, Rolletschek A, Blyszczuk P, Wobus AM. Wiese C, et al. Among authors: kania g. Methods Mol Biol. 2006;325:181-205. doi: 10.1385/1-59745-005-7:181. Methods Mol Biol. 2006. PMID: 16761727

5

Insulin-producing cells.

Schroeder IS, Kania G, Blyszczuk P, Wobus AM. Schroeder IS, et al. Among authors: kania g. Methods Enzymol. 2006;418:315-33. doi: 10.1016/S0076-6879(06)18019-2. Methods Enzymol. 2006. PMID: 17141044

6

Differentiation of mouse embryonic stem cells to insulin-producing cells.

Schroeder IS, Rolletschek A, Blyszczuk P, Kania G, Wobus AM. Schroeder IS, et al. Among authors: kania g. Nat Protoc. 2006;1(2):495-507. doi: 10.1038/nprot.2006.71. Nat Protoc. 2006. PMID: 17406275

7

CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis.

Valaperti A, Marty RR, Kania G, Germano D, Mauermann N, Dirnhofer S, Leimenstoll B, Blyszczuk P, Dong C, Mueller C, Hunziker L, Eriksson U. Valaperti A, et al. Among authors: kania g. J Immunol. 2008 Feb 15;180(4):2686-95. doi: 10.4049/jimmunol.180.4.2686. J Immunol. 2008. PMID: 18250481

8

Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis.

Kania G, Blyszczuk P, Valaperti A, Dieterle T, Leimenstoll B, Dirnhofer S, Zulewski H, Eriksson U. Kania G, et al. Cardiovasc Res. 2008 Nov 1;80(2):236-45. doi: 10.1093/cvr/cvn190. Epub 2008 Jul 11. Cardiovasc Res. 2008. PMID: 18621802 Free article.

9

Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis.

Germano D, Blyszczuk P, Valaperti A, Kania G, Dirnhofer S, Landmesser U, Lüscher TF, Hunziker L, Zulewski H, Eriksson U. Germano D, et al. Among authors: kania g. Am J Respir Crit Care Med. 2009 May 15;179(10):939-49. doi: 10.1164/rccm.200809-1390OC. Epub 2009 Feb 20. Am J Respir Crit Care Med. 2009. PMID: 19234103

10

Heart-infiltrating prominin-1+/CD133+ progenitor cells represent the cellular source of transforming growth factor beta-mediated cardiac fibrosis in experimental autoimmune myocarditis.

Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U. Kania G, et al. Circ Res. 2009 Aug 28;105(5):462-70. doi: 10.1161/CIRCRESAHA.109.196287. Epub 2009 Jul 23. Circ Res. 2009. PMID: 19628793 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters